Goflikicept Withdrawn Phase 3 Trials for Adult Onset Still's Disease / AOSD Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05432960
Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)